Author: Barbuddhe, Sukhadeo Baliram; Rawool, Deepak Bhiwa; Gaonkar, Pankaj Prakash; Vergis, Jess; Dhama, Kuldeep; Malik, Satyaveer Singh
Title: Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic Cord-id: 39d2b0rz Document date: 2020_10_29
ID: 39d2b0rz
Snippet: Severe acute respiratory syndrome Coronavirus- 2 (SARS-CoV-2), the etiological agent of the novel coronavirus disease (COVID-19), has posed a great public health threat to the global community as a pandemic. The origin of the virus has been linked to animals, through a yet-to-be-identified intermediate host. The disease is transmitted to humans mainly through inhalation or contact with infected droplets. The variable clinical presentation of COVID-19 includes fever, cough, sore throat, breathles
Document: Severe acute respiratory syndrome Coronavirus- 2 (SARS-CoV-2), the etiological agent of the novel coronavirus disease (COVID-19), has posed a great public health threat to the global community as a pandemic. The origin of the virus has been linked to animals, through a yet-to-be-identified intermediate host. The disease is transmitted to humans mainly through inhalation or contact with infected droplets. The variable clinical presentation of COVID-19 includes fever, cough, sore throat, breathlessness, fatigue and malaise; however, cutaneous, ocular, neurological, and gastrointestinal manifestations have also been reported. There is an urgent need to strengthen One Health surveillance, intervention, and management strategies to understand the ecology of coronaviruses and to prevent epidemics in the future. Global attention toward the development of treatments, immunotherapies, vaccines, and control options to combat the COVID-19 pandemic has been on an increasing trend. Here, we review the current epidemiological status, public health concerns, and mitigation strategies for COVID-19.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and additional trial: 1
- acute ards respiratory distress syndrome and low airway: 1, 2, 3, 4
- acute respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute respiratory distress syndrome and additional trial: 1
- acute respiratory distress syndrome and adenovirus vector: 1
- acute respiratory distress syndrome and local transmission: 1
- acute respiratory distress syndrome and low airway: 1, 2, 3, 4, 5, 6
- acute respiratory syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and additional approach: 1, 2, 3, 4
- acute respiratory syndrome and additional trial: 1, 2, 3, 4, 5
- acute respiratory syndrome and adenovirus vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute respiratory syndrome and local transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and long term broad: 1, 2
- adaptive immune response and adenovirus vector: 1, 2
- local transmission and long term broad: 1
Co phrase search for related documents, hyperlinks ordered by date